微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -3.84% | 60.09% | -36.11% | 45/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -2.82% | 71.67% | -200.85% | 43/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -0.94% | 6.23% | 93.39% | 39/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -14.18% | 41.77% | -47.46% | 46/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | -9.62% | -657.2% | 3.41% | 49/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | -9.96% | -934.97% | -895.94% | 48/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -1% | -774.54% | 95.89% | 42/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -24.35% | -317.67% | -1817.32% | 45/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | -1.27% | 24.85% | -32.03% | 42/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | -0.96% | 26.73% | -741.56% | 42/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | -0.11% | 82.53% | 98.04% | 36/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -5.83% | -266.67% | -244.97% | 42/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | -1.69% | -34.39% | -28.73% | 33/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | -1.31% | -52.31% | -100.61% | 41/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | -0.65% | 2.89% | 58.84% | 29/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -1.59% | 89.08% | -26.44% | 41/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | -1.26% | -78.72% | -45.9% | 26/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -0.86% | 0.2% | -27.9% | 29/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -0.67% | -149.59% | 95.37% | 22/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | -14.56% | 51.14% | -1969.36% | 44/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | -0.7% | -262.8% | 18.53% | 26/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | -0.86% | -151.4% | -219.85% | 28/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | -0.27% | -125.71% | 99.09% | 25/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | -29.8% | -4950.85% | -6994.96% | 43/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 0.43% | -89.73% | -74.27% | 25/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 1.68% | 8.39% | 60% | 21/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.05% | -0.94% | 277.97% | 21/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | -0.59% | -153.15% | -114.01% | 37/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 4.21% | -24.82% | 171.61% | 21/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 1.55% | -62.92% | 46.23% | 24/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 1.06% | -8.62% | -4.5% | 16/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 1.11% | 362.5% | -80.18% | 28/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 5.6% | 108.18% | 33.97% | 11/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 4.18% | 3700% | 260.34% | 12/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 1.16% | 73.13% | 383.33% | 12/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 0.24% | -90.48% | -91.08% | 25/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 2.69% | 647.22% | 2345.46% | 15/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 0.11% | -88.89% | -83.58% | 15/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 0.67% | -58.9% | -73.41% | 12/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |